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Sulfite-mediated oxidative stress in kidney cells.
Background. Chronic renal failure has been associated with
oxidative stress. Serum sulfite, sulfate, cysteine, homocysteine,
cysteine sulfinic acid, and c-glutamylcysteine are elevated in
patients on hemodialysis, suggesting an accelerated catabolism
of sulfur-containing amino acids or a reduced elimination of
sulfite/sulfate, or both. Administration of metabisulfite has also
been shown to damage kidney cells.
Methods. Measurement of reactive oxygen species (ROS)
was performed with the fluorescence of dichlorofluorescein
(DCF), and that of intracellular ATP was by the luciferin-
luciferase reaction. Oxidation of sulfite and succinate by
isolated mitochondria from rat kidney was monitored po-
larographically. The fluorescent probe, 5, 5′, 6, 6′-tetrachloro-
1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1) was
employed to assess any loss in membrane potential in en-
ergized respiring mitochondria. Activities of glutamate and
malate dehydrogenases (GDH, MDH, respectively) were as-
sayed by the spectrophotometric measurement of NADH. Sul-
fite was determined by HPLC-fluorimetric measurement of
monochlorobimane-sulfite and cell viability was by the MTT
procedure.
Results. An immediate increase in ROS followed exposure
of Madin-Darby canine kidney (MDCK), type II, and opos-
sum kidney (OK) cells to 5–500 lmol/L sulfite. Depletion of
intracellular ATP was also observed. A low rate of oxidation of
100 lmol/L sulfite was observed polarographically in isolated
kidney mitochondria, but ADP-stimulated State 3 respiration
was not apparent. ATP biosynthesis from the oxidation of glu-
tamate in rat kidney mitochondria was significantly inhibited
by coincubation with 100 lmol/L sulfite; this was not the case
with malate, succinate, and TMPD/ascorbate. However, activ-
ities of both GDH and MDH in kidney mitochondrial extract
were inhibited. The mitochondrial membrane potential and cell
viability were not compromised.
Conclusion. Micromolar sulfite elicited an immediate in-
crease in ROS in MDCK, type II, and OK cells. This was ac-
companied by a depletion of intracellular ATP, which could be
explained by its inhibitory effect on mitochondrial GDH. Al-
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though MDH was similarly inhibited, the impact was buffered
by the high level of this enzyme in kidney mitochondria.
The human body is constantly exposed to sulfite
(SO2−3 ), generated from the metabolism of sulfur-
containing amino acids. Human neutrophils can also
produce sulfite from sulfate in response to bacterial
lipopolysaccharide [1], and from 3′-phosphoadenosine
5′phosphosulfate (PAPS), the “active sulfate” [2]. Sulfite
can be inhaled as sulfur dioxide (SO2) or ingested as food
preservatives [3], particularly in wines and drug prepara-
tions. In the treatment of wine, the permitted maximum
of sulfite could be as high as 250 mg/L [4] with millimolar
ranges reported in red and white wines [5]. Drugs admin-
istered to patients via injection, infusion, or orally may
also contain sulfite as stabilizers [6]. Generally, most adult
human subjects are able to metabolize sulfite because of
the presence of sulfite oxidase (SO), which oxidizes sulfite
(SO2−3 ) to sulfate (SO
2−
4 ). The renal SO activity measured
in various tissues of laboratory animals was always lower
than the corresponding level in liver [7–9]. The low and
negligible SO activity in human lung [9] could explain the
phenomenon of sulfite susceptibility in asthmatic subjects
who react adversely to sulfites in food and sulfur dioxide
in the air [10]. Deficiency of SO in humans can be due to
a mutation in the SO gene or any of the several genes in-
volved in the synthesis of molybdopterins. SO deficiency
is known to lead to early death in infancy because of neu-
rologic abnormalities, seizures, and mental retardation
[11–13]. This illustrates the potential toxicity of sulfite in
humans.
In normal human serum, sulfite is present in low con-
centration of 4–5 nmol/L [14]. However, in patients with
chronic renal failure (CRF) or who are on hemodialy-
sis, serum sulfite, cysteine, homocysteine, cysteine sulfinic
acid, and c-glutamyl cysteine are elevated [15–17]. Sulfate
also accumulates, leading to hypersulfatemia [18, 19], sug-
gesting an overall increase in the catabolic pathway of the
sulfur-amino acids methionine and cysteine. Of the inter-
mediates, homocysteine is thought to contribute to the
high cardiovascular risk in these patients [20–22].
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This study attempts to examine the effects of sulfite
on two kidney cell lines, namely Opossum kidney (OK)
and Madin Darby canine kidney (MDCK), type II cells
derived from proximal and distal tubules, respectively.
Preliminary studies showed that intracellular ATP was
depleted by low micromolar sulfite, suggesting that its
target could be on mitochondrial bioenergetics.
METHODS
The following were from Sigma Chemical Co. (St Louis,
MO, USA): ATP, ADP, succinate, glutamate, malate,
oxaloacetate, a-ketoglutarate, N,N,N′,N′-tetramethyl-p-
phenylenediamine (TMPD), ascorbate, antimycin A,
CCCP (carbonyl cyanide m-chlorophenylhydrazone),
dichlorofluorescein diacetate (DCF-DA), NAD, NADH,
and FL-ASC Bioluminescent Somatic cell assay kit.
Monochlorobimane (MCB) and 5, 5′, 6, 6′-tetrachloro-
1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-
1) were from Molecular Probes, Inc. (Eugene, OR, USA).
Sodium sulfite was from Merck, F.R Germany. MTT was
obtained from BDH Laboratory Supplies, Poole, UK.
OK cells were purchased from American Type Culture
Collection (ATCC, Manassas, VA, USA). MDCK type
II cells were kindly provided by Dr. Walter Hunziker of
Institute of Molecular and Cell Biology, Singapore.
Cell culture and sample preparation for measurement
of ATP
MDCK type II and OK cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) contain-
ing 100 units/mL each of penicillin G and streptomycin
and 0.25 lg amphotericin B supplemented with 10% fe-
tal bovine serum (FBS) in a humidified incubator with
5% CO2 at 37◦C. Confluent cells (300,000 per well in
24-well plates) were exposed to freshly prepared sulfite
solutions at final concentrations of 5, 10, 50, 100, and
500 lmol/L in HBSS/glucose medium. Sulfite was omit-
ted in the controls. After a 3-hour incubation, the medium
was removed and the cells were washed once with 1.0 mL
phosphate-buffered saline (PBS). Cells were lysed with
0.5 mL water and sonicated for 30 seconds. The cells were
scraped off the plate and transferred quantitatively into
microfuge tubes. This was followed by boiling in a water
bath for 3 minutes to inactivate any ATP hydrolytic ac-
tivity present in the cell lysates. All samples were stored
frozen at −80◦C and aliquots were removed for analysis
of ATP as described below.
ATP determination
Frozen samples were thawed and centrifuged at
15,000 rpm for 10 minutes in a Beckman (Beckman Coul-
ter, Fullerton, CA, USA) microfuge at 4◦C. Supernatant
(25 lL) was used for ATP determination following the
procedure provided in the Sigma FL-ASC Biolumines-
cent Somatic cell assay kit. Essentially, the assay mixture
contained either 25 lL of cell extract or ATP stan-
dards of 5 to 100 pmol and 100 lL of ATP assay mix
(FL-AAM), which had been diluted 250-fold in adeno-
sine 5′triphosphate (ATP) assay mix dilution buffer
(FL-AAB) solution according to the instructions from
the suppliers. Measurements of the chemiluminescence
of the luciferin-luciferase reaction were made in a Beck-
man liquid scintillation counter, using the single photon
mode as described [23]. This is a reliable and accurate
assay with the added advantage of measuring multiple
samples with ease.
Cell viability by the tetrazolium salt (MTT) assay
MDCK type II and OK cells were cultured in the ab-
sence or presence of 5- to 500-lmol/L sulfite in 96-well
plates overnight. The medium was discarded and the cells
were washed once with PBS. This step is crucial to avoid
interference of sulfite in the MTT assay. Thiazolyl blue
(MTT reagent) (200 lL) was added at a concentration of
0.5 mg/mL cell medium followed by incubation at 37◦C
for 2 hours in a CO2 incubator. The dye solution was
discarded and 100 lL dimethyl sulfoxide (DMSO)
was added to release the formazan product. The well
plate was agitated for 15 minutes before reading at 550 nm
in the microplate-reader (Microplate Autoreader EL311;
Bio-Tek Instruments, Inc., Winooski, VT, USA).
Measurement of sulfite by high-performance liquid
chromatography (HPLC)-radiometry
Freshly prepared sulfite introduced into the culture
medium was analyzed for its stability under the conditions
of our assay procedures. The measurement was based
on the derivatization of sulfite with monochlorobimane
(MCB) followed by HPLC-fluorimetric determination of
the MCB-sulfite product [24]. Modifications of the proce-
dure included the employment of a fixed reaction time of
15 minutes and a temperature of 42◦C for derivatization
to ensure uniformity and to increase the formation of the
MCB-sulfite derivative as recommended by Ji et al [14].
MDCK type II cells (0.3 × 106) were plated in each
well of a 24-well plate. The corresponding control wells
were filled with medium only. Both plates were placed
in a CO2 incubator overnight. The medium was dis-
carded the next morning, and the wells were washed
with HBSS/glucose. A freshly prepared solution of
100 lmol/L sulfite in HBSS/glucose was added to all wells.
Solution (150 mL) was removed immediately for mea-
surement at zero time, and the well plates were returned
to the CO2 incubator. Further aliquots of 150 lL were re-
moved at 0.5, 1, 2, and 3 hours, followed immediately for
each time point by adding 150 lL of 1 mmol/L MCB in
50 mmol/L N-ethylmorpholine, pH 8.0 at 42◦C for 15 min-
utes, and the reaction was terminated by 15 lL of 100%
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trichloroacetic acid (TCA). Following centrifugation, the
supernatant was analyzed for the MCB-sulfite derivative.
The HPLC system consisted of a Hewlett-Packard 1050
connected to a Hewlett-Packard 1046 fluorescence de-
tector (Hewlett-Packard, Palo Alto, CA, USA). A C18
column (46 × 100 cm) containing Hypersil ODS of 5-l
particle size was used with a mobile phase of 9% acetoni-
trile and 0.25% acetic acid adjusted to pH 3.7. The flow
rate was 1 mL per minute. Under these chromatographic
conditions, MCB-sulfite has a retention time of 1.5 to
1.6 minutes.
Measurement of oxidative stress by
dichlorofluorescein-diacetate (DCF-DA)
Quantitative assay. The assay procedure of Wang and
Joseph was employed [25]. Routinely, about 30,000 cells
were seeded in 96-well plates and they were grown
overnight or for two days. On the day of the experiment,
the medium was discarded and the cells were washed
with HBSS/glucose. DCF-DA (50 lL of 100 lmol/L) in
cell-culture medium minus serum was then added to the
wells and the plate was returned to the CO2 incubator for
30 minutes. Any remaining DCF-DA was discarded and
the cells were then washed once with HBSS/glucose.
Sodium sulfite, freshly prepared in HBSS/glucose, was
then added at 5, 10, 50, 100, and 500 lmol/L. The plate was
placed in a microplate reader prewarmed to 37◦C. Read-
ings were taken at 30 minutes at Ex/Em of 490/526 nm
using a microplate reader (Molecular Devices, Gemini
XS, Sunnyvale, CA, USA), and background fluorescence
was subtracted from each corresponding well as recom-
mended [25]. Results were expressed as % increase in
fluorescence and were compared to untreated controls.
Confocal microscopy. MDCK type II and OK cells
(50,000 to 100,000 per well) were plated in 6-well plates
containing three round glass cover slips (15-mm diam-
eter) per well. They were allowed to adhere overnight.
On the day of the experiment, the cells were washed
with PBS before loading with 50 lmol/L DCF-DA in cell
medium minus serum at 37◦C for 30 minutes. The cells
were then washed with HBSS/glucose and exposed to
100 lmol/L sulfite in the same buffer. Sulfite was omitted
in the controls. After 30 minutes of incubation at 37◦C,
the cells were washed with PBS and then fixed with 3.7%
paraformaldehyde in PBS for 10 minutes. Cells on the
cover slips were observed by confocal microscopy (Bec-
ton Dickinson, Franklin Lakes, NJ, USA). Excitation was
by an argon laser beam at 488 nm, and the fluorescence
was imaged through a 515 nm long-pass filter.
Preparation of intact mitochondria for polarographic
measurements and ATP biosynthesis
Male Wistar rats weighing about 150 g were starved
overnight and killed by cervical dislocation. Freshly ex-
cised kidneys (about 1 g) from a rat were washed in ice-
cold isolation buffer of pH 7.5 containing 20 mmol/L Tris,
250 mmol/L sucrose, 40 mmol/L KCl, 2 mmol/L EGTA,
and 1 mg/mL bovine serum albumin (BSA) [26]. The kid-
neys were finely cut with scissors in about 20 mL of the
same isolation medium and homogenized in a glass tube
with a loose fitting Teflon-coated pestle using six upward
and downward strokes. Following centrifugation at 1000 g
for 10 minutes, the pellet was discarded, and the super-
natant was recentrifuged at 10,000 g for 10 minutes. The
resulting pellet was resuspended and centrifuged again at
10,000 g for 10 minutes to obtain a cleaner pellet. To the
latter, 0.5 mL of the same isolation buffer was added to
give a final protein concentration of about 6–10 mg/mL, as
determined by the Bradford procedure [27]. Aliquots of
the mitochondrial preparation containing approximately
300 to 500 lg protein were employed in a total final vol-
ume of 1.5 mL of respiratory buffer for polarographic
measurements.
Polarographic measurement of oxidation of sulfite
and succinate
The assay mixture contained 1.5 mL of a respiratory
buffer made up of 0.1 mol/L KCl, 10 mmol/L Tris, and
12.5 mmol/L KH2PO4 adjusted to pH 7.6. The sub-
strates were added, with their final concentrations
given in parentheses: sulfite (100 lmol/L), succinate
(12.5 mmol/L). Higher concentrations of sulfite were not
used as spontaneous oxidation was observed at and above
500 lmol/L sulfite. The rate of oxygen uptake was mon-
itored at room temperature (25◦C) in a Clark-type oxy-
gen electrode (Hansatech, UK) upon introduction of 20
to 50 lL kidney mitochondrial preparation containing
200 to 500 lg protein. State 3 respiration was initiated
by adding ADP to give a final concentration of 125 or
250 lmol/L (equivalent to 125 or 250 nmol/mL reaction
mixture). Mitochondria prepared with the above proce-
dure showed respiratory control ratios between 2 and 3
with 12.5 mmol/L succinate as substrate.
Measurement of ATP generated by the oxidation of
glutamate, malate, succinate, and TMPD/ascorbate
in the presence and absence of 100 lmol/L sulfite
The assay incubate contained 125 or 250 lmol/L
ADP together with one of the following substrates, with
their final concentrations given in parentheses: glutamate
(5 mmol/L), malate (5 mmol/L), succinate (12.5 mmol/
L), or TMPD (100 lmol/L or 1 mmol/L) plus ascorbate
(5 mmol/L) in the absence or presence of 100 lmol/L
sulfite. The final volume was made up to 1.5 mL with
the respiratory buffer. The reaction was begun by adding
to it 10–15 lL of rat kidney mitochondrial preparation
containing about 0.3 mg protein. After 15-minute incu-
bation at 25◦C, the reacted incubates were boiled for
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3 minutes and centrifuged. Suitable dilutions (10, 20, 100,
or 200 times) of the supernatant were made and 25 lL
aliquots were taken for ATP determination as described
above. This allowed for extrapolation from a standard
curve generated from 5 to 100 pmol ATP, a range that
produced a linear response.
Activities of glutamate dehydrogenase (GDH) and
malate dehydrogenase (MDH)
The assay procedures were based on the spectroscopic
measurement of NADH at 340 nm either in the forward
or reverse reaction catalyzed by the dehydrogenases. The
reaction conditions were as reported for GDH and MDH
[28]. Essentially, the assay mixture for GDH contained
4 mmol/L NAD, 8 mmol/L glutamate, 0.16% (v/v) Triton
X-100 made up to 2.5 mL with 0.1 mol/L phosphate-Tris,
pH 7.7. The reaction was begun by the addition of rat kid-
ney mitochondrial preparation containing 0.5 mg protein.
ADP was not included in the GDH assay as activities were
essentially similar with or without its addition. MDH was
assayed with oxaloacetate (OAA) as the substrate as the
equilibrium of the reaction is in the direction OAA to
malate [29]. The MDH assay contained 0.133 mmol/L ox-
aloacetate, 0.16 mmol/L NADH, 0.16% Triton X-100, and
30 lL of kidney mitochondrial extract containing about
30–40 lg protein. The total final volume was made up to
2.5 mL with potassium phosphate buffer, pH 7.4. This re-
action was begun by adding to it 0.16 mmol/L NADH. The
absorbance of NADH was monitored continuously on a
Beckman DU Spectrophotometer at 25◦C for 5 to 10 min-
utes. The reverse reaction from a-ketoglutarate to gluta-
mate was also started by adding NADH. Activities of
both GDH and MDH were measured in the absence and
presence of sulfite ranging from 5 to 500 lmol/L concen-
tration. Sulfite (100 and 500 lmol/L) added to solutions of
standard assay incubates containing NAD+ (4 mmol/L)
or NADH (0.16 mmol/L) did not interfere with the ab-
sorbance readings at 340 nm.
Monitoring of membrane potential in isolated
mitochondria by JC-1
The mitochondrial membrane potential was moni-
tored by the change in the red peak, corresponding to
the J-aggregates following the uptake of the fluorescent
cyanine dye JC-1 into isolated mitochondria [30]. Res-
piratory buffer (2 mL) was introduced, followed by the
addition of 5 to 20 lL (containing 50–200 lg protein)
of rat kidney mitochondrial preparation and freshly pre-
pared 2 lmol/L JC-1 dissolved in DMSO. Upon addition
of 12.5 mmol/L succinate, the uptake and formation of
the J-aggregates were monitored from 500 to 620 nm
on the Perkin Elmer LS-50B fluorescence luminome-
ter (Buckinghamshire, UK). Following the establishment
of an optimal/maximal J-aggregate peak, 100 lmol/L
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Fig. 1. Loss of sulfite in the presence and absence of Madin Darby
canine kidney (MDCK) type II cells. Sulfite was measured by the high-
performance liquid chromatography (HPLC)-fluorimetric analysis of
monochlorobimane-sulfite. A P value less than 0.05 was considered
significant. ∗P < 0.05; ∗∗P < 0.01, between the two sets of data, where
N = 3. One hundred percent represents 100 lmol/L sulfite originally
added.
sulfite, 1 mmol/L sulfite, or 4 lmol/L carbonyl cyanide
m-chlorophenylhydrazone (CCCP) was then introduced
to examine any change in the mitochondrial membrane
potential.
RESULTS
Fate of sulfite in assay media/incubates
A substantial but gradual loss of 100 lmol/L sulfite
added to HBSS/glucose was observed from 30 minutes to
3 hours. Sulfite was determined by the derivatization of
sulfite with MCB followed by HPLC-fluorimetric anal-
ysis of MCB-sulfite [24]. A greater loss was observed
in the presence of MDCK type II cells; this was signif-
icantly different from the controls without cells at 1- and
3-hour time points (Fig. 1). Nonenzymatic oxidation of
sulfite was not observable in polarographic assays at short
time intervals (less than 10 minutes) for concentration of
5 to 100 lmol/L but was apparent at concentrations of
500 lmol/L and above (data not shown). Thus, measure-
ment of the enzymatic oxidation by isolated respiring mi-
tochondria was only carried out with 100 lmol/L sulfite, a
concentration which was shown in this study to produce
an oxidative stress state and to deplete intracellular ATP
concentration.
Cell viability
Following exposure, sulfite added to the culture
medium was removed and the cells were washed be-
fore the measurement by the MTT assay. The viability
of MDCK type II and OK cells, which had been exposed
to sulfite between 5 and 500 lmol/L concentration for
3 hours, was not compromised (Fig. 2). Similar data (not
shown) were obtained for 24-hour exposure.
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Fig. 2. Cell viability measured at 3 hours by the tetrazolium salt (MTT)
assay following exposure of Madin Darby canine kidney (MDCK)
type II and opossum kidney (OK) cells to sulfite between 5 and
500 lmol/L added to the medium. The medium was discarded and the
cells were washed with phosphate-buffered saline (PBS) before the
MTT assay. No significant difference was observed when compared to
corresponding untreated controls (N = 4). Similar profiles were ob-
served for 24-hour exposure.
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Fig. 3. Increase in reactive oxygen species (ROS) following exposure
to sulfite between 5 and 500 lmol/L measured in opossum kidney (OK)
and Madin Darby canine kidney (MDCK) type II cells. For OK cells,
values for sulfite-treated cells were significantly different from controls
(P < 0.05) for all concentrations of sulfite above 50 lmol/L (N = 4). In
the case of MDCK type II cells, P < 0.01 for all concentrations of sulfite
employed.
Sulfite-mediated changes
Reactive oxygen species (ROS) in whole cells. Mea-
surement of ROS using DCF-DA showed that 5 to
500 lmol/L sulfite produced an increase in fluorescence
of DCF within 30 minutes in MDCK type II and OK
cells (Fig. 3). The increase in ROS was significant at
almost all concentrations of sulfite introduced. Further
comparison of oxidative stress was demonstrated by the
Fig. 4. Confocal microscopy of reactive oxygen species (ROS) follow-
ing uptake of dichlorofluorescein-diacetate (DCF-DA) and exposure
to 100 lmol/L sulfite in Madin Darby canine kidney (MDCK) type II
(A) and opossum kidney (OK) cells (B) compared with untreated cells
shown in the upper panels.
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Fig. 5. Depletion of intracellular ATP by sulfite in opossum kidney
(OK) and Madin Darby canine kidney (MDCK) type II cells, measured
at 3 hours after exposure to sulfite between 5 and 500 lmol/L sulfite.
∗P < 0.05 and ∗∗P < 0.01; N = 3.
increased intensity of DCF in sulfite-treated cells com-
pared with untreated controls measured by confocal
microscopy (Fig. 4A and B).
Depletion of ATP in whole cells. Intracellular ATP
decreased following exposure of OK and MDCK type II
cells to sulfite for 3 hours (Fig. 5). At 100 lmol/L sul-
fite, a significant fall of 40% to 50% ATP was observed,
while at 500 lmol/L sulfite, more than 60% depletion was
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Table 1. Biosynthesis of ATP from oxidation of glutamate, malate,
and succinate by rat kidney mitochondria in the absence or presence
of 100 lmol/L sulfite
Substrate (±100 lmol/L sulfite) ATP, nmol/mL reaction incubate
Glutamate (5 mmol/L) 85 ± 14.2
Glutamate (5 mmol/L) + sulfite 12 ± 1.50a
Malate (5 mmol/L) 72 ± 12.9
Malate (5 mmol/L) + sulfite 69 ± 14.1
Succinate (12.5 mmol/L) 172 ± 6.7
Succinate (12.5 mmol/L) + sulfite 172 ± 15.2
ADP added was 250 lmol/L (=250 nmol/mL).
Values are mean ± SD (N = 4).
aP < 0.001.
Table 2. Biosynthesis of ATP from oxidation of sulfite, succinate, and
TMPD/ascorbate in rat kidney mitochondria in the presence of sulfite
and/or antimycin A
Substrate (±100 lmol/L sulfite ATP nmol/mL
and/or 2 lmol/L AA) reaction incubatea
Succinate (12.5 mmol/L) 84.3 ± 16.6
Succinate (12.5 mmol/L) + sulfite 86.0 ± 2.21
TMPD (1 mmol/L) 58.8 ± 4.99
TMPD (1 mmol/L) + sulfite 61.0 ± 6.05
TMPD (1 mmol/L) + AA 56.5 ± 7.32
TMPD (1 mmol/L) + AA + sulfite 47.5 ± 8.06
Sulfite (100 lmol/L) 12.5 ± 2.64
Sulfite (100 lmol/L) + AA 11.3 ± 1.26
TMPD (100 lmol/L) 49.5 ± 8.96b
TMPD (100 lmol/L) + AA 55.5 ± 7.05b
AA, antimycin A, added to inhibit respiratory complex III. ADP added was
125 lmol/L (125 nmol/mL). Values are mean ± SD (N = 4).
aEach pair of values in this column is not significantly different from each
other where P > 0.05. Routinely, TMPD was added together with 5 mmol/L
ascorbate.
bP < 0.001 compared to corresponding values with sulfite as substrate.
found in both cell lines. Sulfite (100 lmol/L) added to the
ATP standards employed routinely had no effects on the
luciferin-luciferase reaction.
Inhibition of ATP biosynthesis from oxidation of
glutamate in rat kidney mitochondria. ATP was biosyn-
thesized by intact rat kidney mitochondria from the
oxidation of 5 mmol/L glutamate in the presence of
250 lmol/L ADP. However, a significant decrease in
ATP production (86%) was observed upon addition of
100 lmol/L sulfite (Table 1). This was in contrast to the
oxidations of malate, succinate, and TMPD/ascorbate,
which were not affected by sulfite (Tables 1 and 2).
Inhibition of activity of GDH. GDH activity in
rat kidney mitochondrial extract was inhibited by 5–
100 lmol/L sulfite in a concentration-dependent man-
ner when measured in the direction of glutamate to
a-ketoglutarate (Fig. 6A). The activity measured in the
reverse direction was low, and little to no inhibition was
observed even at 500 lmol/L sulfite (Fig. 6B). The initial
velocity was inhibited by about 71% by 100 lmol/L sulfite.
The specific activity of GDH of the kidney mitochondrial
extract was 0.045 lmol/L NADH formed/min/mg protein,
as calculated from a standard of NADH containing 0.1 to
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Fig. 6. Activity of NAD-linked dehydrogenases in rat kidney mito-
chondrial extract measured in the presence and absence of sulfite:
glutamate dehydrogenase (GDH) in the direction of glutamate to
a-ketoglutarate (a-KG) (A); GDH in the direction of a-KG to glutamate
(B); malate dehydrogenase (MDH) in the direction of oxaloacetate to
malate (C).
0.4 lmol/L NADH measured at the same time under sim-
ilar assay conditions.
Inhibition of MDH measured in the direction of ox-
aloacetate to malate. Attempts to measure the MDH
activity in kidney (and liver) mitochondrial extracts in
the direction of malate to oxaloacetate (OAA) were un-
successful because the equilibrium of the MDH is in the
reverse direction [29]. The reaction was rapid in the di-
rection of OAA to malate and the specific activity was
6.06 lmol/L NADH consumed/min/mg protein (i.e., 135
times higher than the GDH activity in the same kidney
mitochondrial extract). MDH activity was also inhibited
in a concentration-dependent manner by sulfite (Fig. 6C).
At 100 lmol/L sulfite, 55% inhibition was observed.
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Fig. 7. Oxidation of 12.5 mmol/L succinate and 100 lmol/L sulfite (in-
sert at bottom) by isolated rat kidney mitochondria. State 3 respiration
was induced by adding 125 lmol/L ADP. No coupling effect was ob-
served with sulfite as the respiratory substrate.
Lack of stimulation of State 3 respiration of sulfite
by ADP
Isolated mitochondria prepared from rat kidney did
not show stimulation of respiration by ADP (125 to
500 lmol/L) when oxidizing 5 to 200 lmol/L sulfite.
This was also observed with rat liver mitochondria (data
not shown). A representative polarographic tracing for
100 lmol/L sulfite is shown in the insert (Fig. 7, bottom).
This contrasts with the oxidation of 12.5 mmol/L succi-
nate which exhibited the coupling effect even in the pres-
ence of sulfite (Fig. 7, top). Sulfite at concentrations of
500 lmol/L and above was oxidized spontaneously and
therefore was not suitable for polarographic assays. How-
ever, the amount of ATP biosynthesized from oxidation
of 100 lmol/L sulfite in the presence or absence of an-
timycin A was substantially lower (about 20%) compared
with that produced by an equimolar concentration of
TMPD plus 5 mmol/L ascorbate (Table 2), although both
sulfite and TMPD enter the mitochondrial electron trans-
port chain via cytochrome c [31].
Parameters not affected by sulfite
Membrane potential in isolated mitochondria. Up-
take and formation of JC-1 aggregates was observed in
isolated rat kidney mitochondria energized by the ox-
idation of 12.5 mmol/L succinate. This pre-established
high mitochondrial membrane potential was not affected
by the introduction of 100 lmol/L or 1 mmol/L sulfite
compared with the marked decrease elicited by 4 lmol/L
CCCP, a classic uncoupler (Fig. 8). It would appear that
the mitochondrial membrane potential was not affected
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Fig. 8. Uptake and aggregation of 5, 5′, 6, 6′-tetrachloro-1,1′,3,3′-
tetraethylbenzimidazolcarbo-cyanine iodide (JC-1) in isolated mi-
tochondria energized by 12.5 mmol/L succinate. The established
peak of JC-1 red aggregate was not affected by 100 lmol/L sulfite
and 1 mmol/L sulfite in contrast to 4 lmol/L carbonyl cyanide m-
chlorophenylhydrazone (CCCP), a classic uncoupler. The peaks at
535 nm and 595 nm represent the monomer (green fluorescence) and
J-aggregates (red fluorescence), respectively.
by sulfite at a concentration that produced increased ox-
idative stress and a depletion of cellular ATP.
ATP production from oxidation of malate, succinate,
TMPD/ascorbate in respiring mitochondria. Oxidation
of sulfite, succinate, malate, and TMPD/ascorbate pro-
duced ATP from ADP and Pi. The amount of ATP
biosynthesized in the presence and absence of 100 lmol/L
sulfite remained unchanged for the above-named sub-
strates (Tables 1 and 2), unlike in the case of gluta-
mate, where a significant decrease in ATP was observed
(Table 1). Polarographic measurement of oxygen uptake
during succinate oxidation was similar in the presence or
absence of 100 lmol/L sulfite (Fig. 7), showing no change
in the electron transport system or coupling of oxidation
to phosphorylation. This concurred with the observation
that the mitochondrial membrane potential was not com-
promised by sulfite as measured by the JC-1 probe, and
that the amount of ATP formed from succinate was sim-
ilar in the presence or absence of sulfite (Tables 1 and
2). It was therefore concluded that the electron trans-
port from respiratory complex II to IV was intact. The
amount of ATP formed from the oxidation of 1 mmol/L
TMPD/5 mmol/L ascorbate was the same in the presence
or absence of 100 lmol/L sulfite (Table 2), confirming that
sulfite did not affect complex IV.
DISCUSSION
There was a gradual loss of sulfite from a freshly pre-
pared 100 lmol/L sulfite solution in HBSS/glucose in
the absence or presence of MDCK type II cells. Thus,
both spontaneous and cell-mediated oxidation of sulfite
appears to occur. The loss was significantly greater in the
presence of cells, suggesting an uptake by MDCK type
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II cells. Sulfite is known to be readily auto-oxidized in
solution [32]. It is also rapidly taken up by hepatocytes,
as shown in experiments with isolated perfused rat liver
and rat hepatocytes [31, 33], and is transported into mito-
chondria [34]. The loss of sulfite from the medium could
be a combination of auto-oxidation, binding to proteins in
culture medium, transport into the cells, and subsequent
uptake into mitochondria, where it is oxidized by sulfite
oxidase (SO), an enzyme present in the intermembrane
space.
Low rates of oxidation of 100 lmol/L sulfite were ob-
served in rat kidney mitochondria and the rate of oxi-
dation was not stimulated by ADP, unlike in the case of
succinate as the respiratory substrate (Fig. 7). In spite of
a lack in State 3 respiration in polarographic measure-
ment, ATP was biosynthesized from sulfite (Table 2),
but the amount of ATP formed from 100 lmol/L sul-
fite was low, only about 20% of that from an equimo-
lar TMPD plus ascorbate (Table 2). Both are substrates
of complex IV, and they enter the mitochondrial elec-
tron transport chain via cytochrome c [31]. The difference
could be explained by the low sulfite oxidase activity in rat
kidney, which has been reported to be 50% or less than
the hepatic value [7–9]. As sulfite had no effect on the
amount of ATP biosynthesized from TMPD/ascorbate
(in the presence or absence of antimycin A) (Table 2), it
was unlikely to have a direct action on complex IV or cy-
tochrome oxidase (COX). Likewise, the oxidation of suc-
cinate, a complex II substrate, produced similar amounts
of ATP, in the presence or absence of sulfite, suggesting
that activities of complex II to IV and the associated ox-
idative phosphorylating activities were not compromised
(Table 2). That oxidative phosphorylating activity was in-
tact was also demonstrated by the maintenance of the
mitochondrial membrane potential in the presence of sul-
fite (Fig. 8). Although COX has previously been reported
to be inactivated by bisulfite possibly by the sulfitolysis
of essential disulfide bonds, millimolar concentrations of
sulfite and long periods of incubation (6 hours) were re-
quired for the inactivation [35]. Sulfitolysis of disulfide
bonds of intracellular glutathione, oxidized form (GSSG)
was also proposed to explain the increase in glutathione,
reduced form (GSH) in the medium during perfusion of
liver with sulfite [33]. Following its uptake, sulfite was
generally believed to react with protein disulfide bonds
to form protein-S-sulfonates [36]. Thus, sulfite is normally
present in human serum in a bound form [14]. However,
in a reducing environment such as liver (and possibly kid-
ney) where the ratio of RSH:RSSR of 102–103 exists, a re-
lease of sulfite from S-sulfocysteine was implicated [37].
The prolonged elevated serum sulfite observed in kid-
ney dialysis patients [15, 16] could be potentially dam-
aging to renal cells. Besides sulfite, other intermediates
of the transfurylation pathway, namely cysteine sulfinic
acid, c-glutamylcysteine, cysteine, and homocysteine also
accumulate in chronic kidney failure, the last of which is
believed to be responsible for the cardiovascular risk [17,
20–22].
Assuming that the sulfite that was lost from the culture
medium as observed in this study (Fig. 1) did eventually
enter the mitochondrial electron transport chain and is
oxidized to sulfate, an increase in the production of ATP
would be expected in tissues possessing sulfite oxidase
activity. The oxidation of sulfite (SO2−3 ) to sulfate (SO
2−
4 )
involves the transfer of electrons from cytochrome c to
cytochrome oxidase to generate one ATP per sulfite oxi-
dized [31]. On the contrary, we showed a depletion of in-
tracellular ATP in both kidney cell lines examined (Fig. 5)
and in HepG2 cells (data not shown). This observation
directed our efforts to examine the mitochondrion as a
possible target of sulfite action.
Interestingly, 100 lmol/L sulfite inhibited ATP biosyn-
thesis from the oxidation of glutamate, a substrate of res-
piratory complex I (Table 1). As the inhibitory effect was
not observed with malate, another complex I substrate,
its action on NADH dehydrogenase (complex I) was ex-
cluded. Indeed, the inhibitory effect by sulfite (71%) was
apparent on GDH (Fig. 6A). Inhibition of MDH, mea-
sured in the direction of reduction of OAA to malate,
was also observed (Fig. 6C); the magnitude of inhibition
was 55%. However, the biosynthesis of ATP from malate
was not affected by sulfite (Table 1). The difference in spe-
cific activities of the two dehydrogenases (135-fold higher
in MDH compared with GDH) could explain why sul-
fite had an adverse effect on ATP biogenesis in intact
mitochondria from glutamate but not malate (Table 1).
With such an excess of MDH activity, ATP production
from malate was apparently not affected by sulfite in the
kidney.
In the kidney, glutamate metabolism is initiated by
GDH [38]. The oxidative deamination of glutamate
to form a-ketoglutarate (aKG) and NADH is a key
metabolic pathway and a potential source of energy for
renal cells. Glutamine taken up from the circulation by
kidneys of several species of animals including humans
[39–42] provides a source of glutamate for the GDH re-
action. An inhibition of GDH would reduce ATP biosyn-
thesis via the mitochondrial electron transport system.
This was observed in our study and the degree of inhi-
bition was substantial (Table 1). Previous papers have
shown the potential of sulfite to generate reactive free
sulfite radicals [43–45]. A spin-trapping agent for free
sulfite radicals (SO−3 ), 5-diethoxyphosphoryl-5-methyl-1-
pyrroline-n-oxide (DEPMPO) [46] was employed to ex-
amine their involvement in the oxidative stress, which was
apparent within 30 minutes on cell exposure to micromo-
lar sulfite. This was excluded as a possible mechanism
because the amounts of ATP produced by cells with and
without sulfite (5 to 500 lmol/L) were the same in the
presence or absence of DEPMPO (unpublished data).
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Based on the observations made in this study on cul-
tured renal cells (OK and MDCK type II) and isolated
rat kidney mitochondria, it is proposed that the action of
sulfite on GDH would reduce the electron flow via respi-
ratory complex 1, particularly so because glutamate is a
major substrate. This could initiate an oxidative stress
with a fall in intracellular ATP or the oxidative stress
could be a parallel event. In either case, the oxidative
stress, decreased ATP level, or impaired catabolism of
glutamate could decrease renal functions. This concurred
with studies in vivo where chronic administration of bisul-
fite to rats produced significant changes in activities of nu-
merous enzymes in the serum and urine of rats, indicating
severe damage to kidney cells [47, 48].
The activity of human kidney sulfite oxidase is un-
known; it is probably lower than that of the human hep-
atic value, as is the case with all experimental animals
examined [7–9]. Data from our laboratory showed low
SO expression in human kidney compared with human
liver [49]. An earlier report estimated that SO of human
liver is only 10% to 20% of that of rat liver [50]. With
such a low SO activity in human kidney, accumulation
of sulfite could occur especially in CRF. However, with
the accompanying hypersulfatemia in CRF [18, 19], it is
likely that the overall transulfurylation pathway shown
below is increased.
Methionine → homocysteine → cystathionine → cys-
teine → cysteine sulfinic acid → sulfite → sulfate.
CONCLUSION
In this study, it was demonstrated that a single micro-
molar dose of sulfite elicited an immediate increase in
ROS production. Chronic renal failure is known to be as-
sociated with oxidative stress, which contributes to pro-
tein and lipid oxidation in end-stage renal disease [51],
but the mechanism is unknown. Increased oxidant stress
could be a major contributor to cardiovascular morbidity
and mortality in chronic dialysis patients [52]. A recent
report proposed that a dysregulation of superoxide dis-
mutase and NADPH oxidase could be responsible for the
oxidant stress [53].
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